GSK Is First To Share Cancer Drug Patents With Poor Countries
This article was originally published in SRA
Executive Summary
GlaxoSmithKline PLC intends to make a big splash in the Medicines Patent Pool as the first company to share its future cancer drug patents for development of generic drugs in least developed and low-income countries and certain middle-income countries1.